Navigation Links
Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008
Date:2/5/2008

PURCHASE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), a growing developer and marketer of nutritional supplements under the Chromax(R), Diabetes Essentials(TM) and Iceland Health(R) brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory, and address chronic joint pain, will report financial results for the second quarter of fiscal year 2008, ended December 31, 2007 on Monday, February 11, 2008, after market close. The Company has scheduled a conference call to discuss the results of the quarter on Tuesday, February 12, 2008, at 8:30AM ET.

Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call is available by visiting http://www.nutrition21.com for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 32156566, through February 14, 2008.

About Nutrition 21

Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness brands include: Chromax(R), Core4Life(TM
'/>"/>

SOURCE Nutrition 21, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
2. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
3. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
4. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
5. Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area
6. Pilot Therapeutics Announces New Executive Team with Extensive Experience Creating New Health and Nutrition Businesses
7. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
8. Salugen to Present at Nutrition Capital Networks First In-Person Investor Meeting
9. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists
10. Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
11. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Contec’s Sporicidin disinfectant solut...grade disinfectants against H1N1 and Influenza A.,...) November 24, 2009 -- Contec Inc, the leading man...that their Sporicidin disinfectants have been de... A viruses, including Pandemic 2009 H1N1 influenza...
(Date:11/23/2009)...ov.23/PRNewswire/-InimexPharmaceuticals,Inc.announ...sPresidentandCEO. ,, Abramsbringsmorethan25year...eisaco-inventorofthenuclearmedicineimagingagent,Ca...lcwherehewasManager,BiomedicalResearchWorldwide.In...CandwasPresidentandCEOfrom1996to2006.AnorMEDdiscov...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire/--PearlTherapeuticsInc.,a...ctsforthetreatmentofchronicrespiratorydiseases,tod...sBoardofDirectors.Mr.Rosenhas25yearsofexperiencein...ingkeyrolesatGileadSciencesandALZACorporation.Hisa...ardtosix. ,, "Howiebringsawealthofproductdevelo...
(Date:11/20/2009)..., , , , , , , ,...AUDIO: , A team of scientists from Washington...a, Cold Spring Harbor Laboratory and Iowa State Un...The... , , Click here for more in... , , , , , , , ...
Breaking Biology Technology:Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Inimex Announces Appointment of New CEO 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...Pharsight,s Diabetes Meta-Database to Quantify Co...-Based Decision-Making,...ation (OTC Bulletin Board: PHST), a leading provid...ng clinical drug development, today,announced that...s,meta-database to a global biotechnology company....
...cals,Inc. (Nasdaq: ANDS ), a biopharmaceutical co...zation of novel medicines for the treatment of,hep...nnounced that Steve,Worland, Ph.D. has been promot...e Officer, replacing Lawrence C. Fritz, Ph.D. who ...as also been appointed as a member of the,Company,...
...ics NV (Euronext,Brussels: THR), a biotechnology c...es a business update and its financial results for...g this period, ThromboGenics has raised,additional...as continued to,make good progress with its clinic...a total of 5,166,517 shares, which increased,the c...
Other Biology Technology:Pharsight Achieves First License Sale for Public-Source Database 2Pharsight Achieves First License Sale for Public-Source Database 3Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer 2Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer 3ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 2ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 3ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 4ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 5ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 6ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 7ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 8ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 9ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 10ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007 11
(Date:11/23/2009)..., DURHAM, N.H. University of New Hampshire mic...aling $498,115 to advance understanding of the act...ential to enrich nutrient-poor and contaminated so...ure (USDA) awarded Tisa, a professor of molecular,...lore the symbiotic relationship between the bacter...
(Date:11/23/2009)..., , , , , , , , , , ... , , AUDIO: , Dr Andrew Mar...ersity of York, discusses the discovery of Kinyon... , Click here for more information... , , , , , , , ...
(Date:11/23/2009)..., Carlos Mara Romeo Casabona is Director of the I... Genome at Deusto University and the University of...made up of jurists but also has other experts such..., medicine and even specialists in ethics. , The...ne Genome at the Universities of Deusto and the Ba...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Research and legislation should go hand in hand, as much as possible 2FDA Approves LIVALO 28R 29 for Primary Hypercholesterolemia and Combined Dyslipidemia 53559 1FDA Approves LIVALO 28R 29 for Primary Hypercholesterolemia and Combined Dyslipidemia 53559 2FDA Approves LIVALO 28R 29 for Primary Hypercholesterolemia and Combined Dyslipidemia 53559 3FDA Approves LIVALO 28R 29 for Primary Hypercholesterolemia and Combined Dyslipidemia 53559 4Corrected 3A Secretary of Health Urges Pennsylvanians to Get Immunized 53557 1Corrected 3A Secretary of Health Urges Pennsylvanians to Get Immunized 53557 2Corrected 3A Secretary of Health Urges Pennsylvanians to Get Immunized 53557 3W M Keck Foundation Awards 241 Million to Hutchinson Center Scholar to Study How Cells Go Awry 13337 1W M Keck Foundation Awards 241 Million to Hutchinson Center Scholar to Study How Cells Go Awry 13337 2
... " Vaccine " published a paper by the Massachusett...ing that a protein sequence important in neurodege...s a new generation of vaccine adjuvants. , The m... elicits specific immunity to a particular virus, ...antigens is one of the most pressing medical and p...
...itute of Singapore (GIS), a research institute ,of...logy and Research (A*STAR), and the University of ...acological approach to kill colon cancer cells. ,...of a protein called Wnt/β-catenin, which is o...ignance, play important roles in ,colorectal cance...
...ists were surprised with findings of a recent stud...sist in small contained areas actually need broad,...more species at risk of extinction today than any ...tudy published in the debut issue of Conservation... protection for many species worldwide. Scientist...
Other Biology News:A protein sequence associated with Huntington’s disease may become life-saving vaccine component 2New study reveals large scale conservation essential 2New study reveals large scale conservation essential 3
...rotein is in solution or in a gel piece, we can id...roteins will be digested to produce a mixture of p...des are determined by MALDI-TOF, and the amino aci...LDI-TOF will be determined by MALDI-TOF/TOF. The m...
Factor Xa Protease from QIAGEN
...s for interferons are cytopathic effect inhibition...Sample types include; tissue culture supernatents;... In these assays, one unit is defined as the quant...e the cytopathic effect of viral infection by 50%....
...s for interferons are cytopathic effect inhibition...Sample types include; tissue culture supernatents;... In these assays, one unit is defined as the quant...e the cytopathic effect of viral infection by 50%....
Biology Products: